for patients with asthma and chronic obstructive pulmonary disease (COPD). Teva noted it is the first and only digital rescue inhaler indicated in patients four years or older for the treatment ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... based rescue medicine to be cleared ...
Early identification and treatment of patients with COPD at risk of exacerbation are crucial for better outcomes. Single-inhaler triple therapy (SITT) users showed improved exacerbation rates and ...